Skip to content
NHS Scotland Logo Scottish Paediatric & Adult Haemoglobinopathies Network

Menu

  • Home
  • About Us
  • Patients and Families
  • Professional zone
  • News and Events
  • Contact us
  1. Home
  2. Professional zone
  3. Paediatric Protocols/Guidance

Back to   Professional zone

Paediatric Protocols/Guidance

Acute Guidance

  • Acute abdominal pain in children with Sickle Cell disease
  • Acute Anaemia
  • Acute Chest Syndrome
  • Chronic Transfusion in Thalassaemia
  • Monitoring and management of endocrine complications in children with transfusion dependent thalassemia (TDT)
  • Endocrine complications in children with Thalassaemia
  • Exchange Transfusion
  • Hydroxycarbamide in Sickle Cell disease
  • Inpatient Specialist Management of acutely unwell children with haemoglobinopathies
  • Iron overload and chelation therapy
  • Management of Hyperhaemolysis in patients with Sickle Cell disease
  • Management of Priapism in Sickle Cell disease
  • Painful Sickle Cell crisis (management)
  • Physiotherapy guideline for the acute management of paediatric & adult patients with Sickle Cell disease
  • Stem Cell Transplant
  • Stroke and other CNS manifestations
  • Surgery and Anaesthesia
  • Transcranial Doppler (TCD) screening for Sickle Cell disease
  • Diagnosis and Management of Non-Transfusion-Dependent Thalassaemia (NTDT) phenotypes
  • Vaccination

Guidance due for review is being considered by the SPAH Guidance subgroups.  Information contained within the guidance has been approved to remain in the website.

Professional zone

  • Adult Protocols/Guidance
  • Paediatric Protocols/Guidance
  • Non SPAH Guidance (paediatric and adult)
  • Pathways and Referral Forms
  • Checklists
  • Educational resources
  • Manual Red Cell Exchange
  • Information leaflets
  • CAS/IT/Audit

This website is managed by NHS National Services Scotland on behalf of NHS Scotland

Support links

  • National Networks
  • Accessibility
  • Disclaimer
  • Privacy
  • Contact us

© Copyright, Scottish Paediatric & Adult Haemoglobinopathies Network 2025